Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HLA-DR antigens in progressive systemic sclerosis (scleroderma).

T L Whiteside, T A Medsger, G P Rodnan

    The Journal of Rheumatology
    |February 1, 1983
    PubMed
    Summary

    This study investigated genetic links to progressive systemic sclerosis (PSS) in North American white patients. While no strong associations were found with common HLA-DR types, a weak link between HLA-DR1 and diffuse scleroderma was observed.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Natural History of Progressive Systemic Sclerosis (difuse Scleroderma).

    Indian journal of dermatology and venereology·2017
    Same author

    There is a need for new systemic sclerosis subset criteria. A content analytic approach.

    Scandinavian journal of rheumatology·2017
    Same author

    Endothelial dysfunction is present only in the microvasculature and microcirculation of early diffuse systemic sclerosis patients.

    Clinical and experimental rheumatology·2014
    Same author

    Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study.

    Annals of the rheumatic diseases·2006
    Same author

    The Lupus Foundation as an additional source for case ascertainment: developing a community-based lupus registry.

    Arthritis care and research : the official journal of the Arthritis Health Professions Association·2003
    Same author

    The assessment of the patient with systemic sclerosis. Introduction.

    Clinical and experimental rheumatology·2003

    Area of Science:

    • Immunogenetics
    • Rheumatology
    • Autoimmune Diseases

    Background:

    • Progressive systemic sclerosis (PSS) is an autoimmune disease with complex etiology.
    • Genetic factors, particularly those within the major histocompatibility complex (MHC), are implicated in autoimmune diseases.
    • Previous studies have suggested associations between PSS and specific Human Leukocyte Antigen (HLA) alleles.

    Purpose of the Study:

    • To investigate the association between HLA-DR alleles and progressive systemic sclerosis (PSS) in a North American white patient cohort.
    • To determine if specific HLA-DR antigens or haplotypes are risk factors for PSS.
    • To explore potential correlations between HLA-DR types, clinical variants of PSS, and autoantibody status.

    Main Methods:

    • Human Leukocyte Antigen (HLA)-DR typing was performed on 125 North American white patients diagnosed with PSS.
    • Patient data included clinical presentation and autoantibody status, such as anticentromere antibodies.
    • Statistical analysis was conducted to compare allele frequencies with local control populations and assess associations with clinical features and autoantibodies.

    Main Results:

    • No significant association was found between PSS and the HLA-DR5 antigen or the HLA-B8/DR3 haplotype.
    • A weak but statistically significant association was observed between the HLA-DR1 antigen and PSS, particularly with diffuse scleroderma (27.5% vs 11.5% in controls, corrected p < 0.05).
    • HLA-DR1 was significantly associated with the presence of anticentromere antibodies, and this combination was more frequent in patients with the CREST syndrome variant of PSS.

    Conclusions:

    • This study did not establish a clear-cut association between progressive systemic sclerosis and genetic factors linked to the major histocompatibility complex in the studied population.
    • A weak association suggests HLA-DR1 may play a role in specific subtypes of PSS, particularly those with anticentromere antibodies and the CREST syndrome.
    • Further research with larger cohorts is warranted to fully elucidate the role of HLA-DR and other genetic factors in the pathogenesis of PSS.

    Related Experiment Videos